Abstract:Objective Compelling evidence suggests that gut microbiota can play a role in the development of the metabolic syndrome, which incorporates abdominal obesity, hypertension, hyperglycaemia and dyslipidaemia. It is known that effective lifestyle intervention (including increasing physical exercise and calorie-restricted diet) is the mainstay treatment for the majority of patients with non-alcoholic fatty liver disease (NAFLD) and prediabetes. However, the effect of aerobic exercise and dietary intervention on gut microbiota in pre-diabetic patients with NAFLD is largely unknown and needs to be elucidated. Thus, the aim of the study was to investigate whether gut microbiota composition would change after aerobic exercise training and a fibre-enriched diet intervention in pre-diabetic patients with NAFLD. Methods We have conducted a randomized controlled trial in patients aged 50-65-year who have fulfilled the inclusion criteria (impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) and hepatic fat content >5.6%, NAFLD). The patients were randomly assigned to aerobic exercise (AEx), dietary intervention (Diet), aerobic exercise plus diet intervention (AED) or no intervention (NI) groups for an average period of 8.6 months (7-11 months). Among those participants, 78 provided fecal samples (AEx, n = 18, Diet, n = 22, AED = 21, and NI = 17). Progressive supervised aerobic exercise training (60-75% intensity) was given 2-3 times/week in 30-60 min/sessions, and the diet intervention was provided as lunch with 38% carbohydrate and diet fibre of 12g per day for 8.6-months. The hepatic fat content (HFC) was assessed by 1H MRS, glycated hemoglobin (HbA1c) and insulin sensitivity were assessed by conventional methods. Gut microbiota characterizations were determined with 16S rDNA-based high-throughput sequencing by Illumina Miseq platform. Results The Simpson index showed that alpha diversity was significantly different in intervention groups compared with NI group after the intervention (AEx vs NI, p=0.070; Diet vs NI, p=0.014; AED vs NI, p=0.011). Simpson index had a negative trend with HFC change % after intervention (r=-0.254, p=0.053). Weighted UniFrac PCoA analysis revealed that the structure of gut microbiota in the intervention groups was significantly differed from that of NI group (AEx vs NI, p<0.01, Diet vs NI, p<0.05, AED vs NI, p<0.001). Interestingly, we found that Erysipelotrichi (which has been reported associated with NASH) was negatively correlated VO2max (r=-0.274, p=0.040). At genus level, Clostridium and Lactobacillus were positively correlated with HFC change after intervention (r=0.273, p=0.038; r=0.273, p=0.041 respectively). Conclusions The exercise and diet intervention modified the structure of gut microbiota both in alpha and beta diversity. The Clostridium and Lactobacillus is related to energy metabolism and participated in the fermentation of carbohydrate which may be partly explain the positive correlation of gut microbiota with HFC change. However, the function of specific gut microbe needs to be further studied.

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients

Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus Study

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-Alcoholic Fatty Liver Disease

Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors' Combination

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies

Effect of 1-year lifestyle intervention with energy-reduced Mediterranean diet and physical activity promotion on the gut metabolome and microbiota: a randomized clinical trial

Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis

PO-240 Effects of Aerobic Exercise and Fiber-Enriched Diet on Gut Microbiota in Pre-Diabetic Patients with NAFLD

Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease

Mediterranean-Oriented Dietary Intervention Is Effective to Reduce Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: Results from an Italian Clinical Trial

The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease

[TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)]

Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

Microbial Intervention As a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression

Influence of Adherence to the Mediterranean Diet and Level of Physical Activity with Liver Steatosis in People Aged > 50 Years and with a BMI > 25 kg/m2: Association with Biochemical Markers